Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

By Aogi Kenjiro   Masuda Norikazu   Ohno Shinji   Oda Takashi   Iwata Hiroji   Kashiwaba Masahiro   Fujiwara Yasuhiro   Kamigaki Shunji   Ito Yoshinori   Ueno Takayuki   Takashima Shigemitsu  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 829-838

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine: In Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer

By Moen Marit D.   Wellington Keri  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 327-333

Adis International

Access to resources Recommend Favorite

Definition of An Optimal First-line Chemotherapy in Metastatic Breast Cancer

By Heinemann Volker  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 43-48

Springer Publishing Company

Access to resources Recommend Favorite

First-Line Chemotherapy with Weekly Paclitaxel and Carboplatin for Advanced Ovarian Cancer: A Phase I Study

By Sehouli J.   Stengel D.   Elling D.   Ortmann O.   Blohmer J.   Riess H.   Lichtenegger W.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 321-326

Academic Press

Access to resources Recommend Favorite